{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T04:21:30Z","timestamp":1793506890615,"version":"4.5.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T00:00:00Z","timestamp":1757376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>ROSAH (retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) syndrome is a rare genetic disease caused by variants in alpha-kinase 1 (ALPK1) resulting in downstream pro-inflammatory signaling mediated by the TIFA\/TRAF6\/NF-\u03baB pathway. Here, we report the design of an ALPK1 inhibitor, DF-003, with pharmacokinetic properties suitable for daily oral dosing. In biochemical assays, DF-003 potently inhibits human ALPK1 (IC<jats:sub>50<\/jats:sub>\u2009=\u20091.5\u2009nM) and the ROSAH disease-causing mutant ALPK1[T237M] (IC<jats:sub>50<\/jats:sub>\u2009=\u200916\u2009nM). When tested against a panel of 394 human kinases, DF-003 exhibits \u2265860-fold selectivity over the closest kinase. In cell-based assays, DF-003 suppresses inflammatory cytokine signaling mediated both by wild-type ALPK1 and the disease-causing ALPK1[T237M] mutant. Using mice heterozygous for wild-type human <jats:italic>ALPK1<\/jats:italic> and <jats:italic>ALPK1<\/jats:italic>\n            <jats:sup>\n              <jats:italic>T237M<\/jats:italic>\n            <\/jats:sup> established to model ROSAH syndrome that exhibit retinal microglial infiltration, astrocyte activation, and inflammatory cytokine upregulation in the retina, optic nerve, and cortex, we show that orally administered DF-003 is sufficient to inhibit these inflammatory phenotypes.<\/jats:p>","DOI":"10.1038\/s41467-025-63731-5","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T11:33:11Z","timestamp":1757417591000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Discovery of a selective alpha-kinase 1 inhibitor for the rare genetic disease ROSAH syndrome"],"prefix":"10.1038","volume":"16","author":[{"given":"Jieqing","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Ming","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaixin","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfang","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengle","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangbin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaru","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junlin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyue","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong-Ruei R.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Melvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeysen","family":"Yogaratnam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Lichenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3689-5945","authenticated-orcid":false,"given":"Cong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"63731_CR1","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ajmg.a.34437","volume":"158","author":"SK Tantravahi","year":"2012","unstructured":"Tantravahi, S. K. et al. An inherited disorder with splenomegaly, cytopenias, and vision loss. Am. J. Med. Genet. A 158, 475\u2013481 (2012).","journal-title":"Am. J. Med. Genet. A"},{"key":"63731_CR2","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1038\/s41436-019-0476-3","volume":"21","author":"LB Williams","year":"2019","unstructured":"Williams, L. B. et al. ALPK1 missense pathogenic variant in five families leads to ROSAH syndrome, an ocular multisystem autosomal dominant disorder. Genet. Med. 21, 2103\u20132115 (2019).","journal-title":"Genet. Med."},{"key":"63731_CR3","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/annrheumdis-2022-222629","volume":"81","author":"CT Kozycki","year":"2022","unstructured":"Kozycki, C. T. et al. Gain-of-function mutations in ALPK1 cause an NF-\u03baB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome. Ann. Rheum. Dis. 81, 1453\u20131464 (2022).","journal-title":"Ann. Rheum. Dis."},{"key":"63731_CR4","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41586-018-0433-3","volume":"561","author":"P Zhou","year":"2018","unstructured":"Zhou, P. et al. Alpha-kinase 1 is a cytosolic innate immune receptor for bacterial ADP-heptose. Nature 561, 122\u2013126 (2018).","journal-title":"Nature"},{"key":"63731_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s00018-020-03577-w","volume":"78","author":"D Garc\u00eda-Weber","year":"2021","unstructured":"Garc\u00eda-Weber, D. & Arrieumerlou, C. ADP-heptose: a bacterial PAMP detected by the host sensor ALPK1. Cell. Mol. Life Sci. 78, 17\u201329 (2021).","journal-title":"Cell. Mol. Life Sci."},{"key":"63731_CR6","unstructured":"Liu, D. et al. Alpha Protein Kinase 1 Inhibitors and Methods of Use. https:\/\/www.patents.google.com\/patent\/US20240109853A1\/ko (2022)."},{"key":"63731_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-33459-7","volume":"13","author":"D Garc\u00eda-Weber","year":"2023","unstructured":"Garc\u00eda-Weber, D. et al. In vitro kinase assay reveals ADP-heptose-dependent ALPK1 autophosphorylation and altered kinase activity of disease-associated ALPK1 mutants. Sci. Rep. 13, 6278 (2023).","journal-title":"Sci. Rep."},{"key":"63731_CR8","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1126\/science.adk7314","volume":"385","author":"Y Tang","year":"2024","unstructured":"Tang, Y. et al. The \u03b2-d-manno-heptoses are immune agonists across kingdoms. Science 385, 678\u2013684 (2024).","journal-title":"Science"},{"key":"63731_CR9","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.celrep.2017.08.039","volume":"20","author":"S Zimmermann","year":"2017","unstructured":"Zimmermann, S. et al. ALPK1-and TIFA-dependent innate immune response triggered by the Helicobacter pylori type IV secretion system. Cell Rep. 20, 2384\u20132395 (2017).","journal-title":"Cell Rep."},{"key":"63731_CR10","doi-asserted-by":"publisher","first-page":"e1009787","DOI":"10.1371\/journal.ppat.1009787","volume":"17","author":"J Cui","year":"2021","unstructured":"Cui, J. et al. The ALPK1 pathway drives the inflammatory response to Campylobacter jejuni in human intestinal epithelial cells. PLoS Pathog. 17, e1009787 (2021).","journal-title":"PLoS Pathog."},{"key":"63731_CR11","doi-asserted-by":"publisher","first-page":"e1006224","DOI":"10.1371\/journal.ppat.1006224","volume":"13","author":"M Milivojevic","year":"2017","unstructured":"Milivojevic, M. et al. ALPK1 controls TIFA\/TRAF6-dependent innate immunity against heptose-1, 7-bisphosphate of gram-negative bacteria. PLoS Pathog. 13, e1006224 (2017).","journal-title":"PLoS Pathog."},{"key":"63731_CR12","doi-asserted-by":"crossref","unstructured":"Xu, C. et al. Alpha-kinase 1 (ALPK1) agonist DF-006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B. Hepatology 77, 275\u2212289 (2023).","DOI":"10.1002\/hep.32614"},{"key":"63731_CR13","doi-asserted-by":"publisher","first-page":"e2313148120","DOI":"10.1073\/pnas.2313148120","volume":"120","author":"T Snelling","year":"2023","unstructured":"Snelling, T., Saalfrank, A., Wood, N. T. & Cohen, P. ALPK1 mutants causing ROSAH syndrome or Spiradenoma are activated by human nucleotide sugars. Proc. Natl. Acad. Sci. USA 120, e2313148120 (2023).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63731_CR14","doi-asserted-by":"crossref","unstructured":"Agarwal, P. et al. Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1. Nature 642, 201\u2013211 (2025).","DOI":"10.1038\/s41586-025-08938-8"},{"key":"63731_CR15","doi-asserted-by":"crossref","unstructured":"Lequain, H. et al. ROSAH syndrome: childhood-onset arthritis, hand deformities, uveitis, and splenomegaly. Lancet Rheumatol. 5, e564 (2023).","DOI":"10.1016\/S2665-9913(22)00360-5"},{"key":"63731_CR16","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10875-020-00741-6","volume":"40","author":"L Zhong","year":"2020","unstructured":"Zhong, L. et al. Juvenile onset splenomegaly and oculopathy due to germline mutation in ALPK1. J. Clin. Immunol. 40, 350\u2013358 (2020).","journal-title":"J. Clin. Immunol."},{"key":"63731_CR17","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.ophtha.2022.10.026","volume":"130","author":"LA Huryn","year":"2023","unstructured":"Huryn, L. A. et al. Ophthalmic manifestations of ROSAH (Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and headache) syndrome, an inherited NF \u03baB\u2013mediated autoinflammatory disease with retinal dystrophy. Ophthalmology 130, 423\u2013432 (2023).","journal-title":"Ophthalmology"},{"key":"63731_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-2094-11-26","volume":"11","author":"Z Tang","year":"2014","unstructured":"Tang, Z. et al. CX3CR1 deficiency suppresses activation and neurotoxicity of microglia\/macrophage in experimental ischemic stroke. J. Neuroinflam. 11, 1\u201313 (2014).","journal-title":"J. Neuroinflam."},{"key":"63731_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/j.1750-3639.1994.tb00838.x","volume":"4","author":"LF Eng","year":"1994","unstructured":"Eng, L. F. & Ghirnikar, R. S. GFAP and astrogliosis. Brain Pathol. 4, 229\u2013237 (1994).","journal-title":"Brain Pathol."},{"key":"63731_CR20","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1073\/pnas.1117213109","volume":"109","author":"C-Y Cui","year":"2012","unstructured":"Cui, C.-Y. et al. Forkhead transcription factor FoxA1 regulates sweat secretion through Bestrophin 2 anion channel and Na-K-Cl cotransporter 1. Proc. Natl. Acad. Sci. USA 109, 1199\u20131203 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63731_CR21","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.3389\/fimmu.2019.01975","volume":"10","author":"K Rashid","year":"2019","unstructured":"Rashid, K., Akhtar-Schaefer, I. & Langmann, T. Microglia in retinal degeneration. Front. Immunol. 10, 1975 (2019).","journal-title":"Front. Immunol."},{"key":"63731_CR22","doi-asserted-by":"crossref","unstructured":"Formichella, C. R., Abella, S. K., Sims, S. M., Cathcart, H. M. & Sappington, R. M. Astrocyte reactivity: a biomarker for retinal ganglion cell health in retinal neurodegeneration. J. Clin. Cell. Immunol. 5, 188 (2014).","DOI":"10.4172\/2155-9899.1000188"},{"key":"63731_CR23","doi-asserted-by":"publisher","first-page":"3079","DOI":"10.1021\/acs.orglett.7b01158","volume":"19","author":"S Inuki","year":"2017","unstructured":"Inuki, S. et al. Chemical synthesis of d-glycero-d-manno-heptose 1,7-bisphosphate and evaluation of its ability to modulate NF-kappaB activation. Org. Lett. 19, 3079\u20133082 (2017).","journal-title":"Org. Lett."},{"key":"63731_CR24","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1016\/S0008-6215(03)00319-7","volume":"338","author":"A Zamyatina","year":"2003","unstructured":"Zamyatina, A. et al. Efficient chemical synthesis of both anomers of ADP L-glycero- and D-glycero-D-manno-heptopyranose. Carbohydr. Res. 338, 2571\u20132589 (2003).","journal-title":"Carbohydr. Res."},{"key":"63731_CR25","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1021\/ja00059a023","volume":"115","author":"MM Sim","year":"1993","unstructured":"Sim, M. M., Kondo, H. & Wong, C. H. Synthesis and use of glycosyl phosphites: an effective route to glycosyl phosphates, sugar nucleotides, and glycosides. J. Am. Chem. Soc. 115, 8 (1993).","journal-title":"J. Am. Chem. Soc."},{"key":"63731_CR26","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1002\/ejoc.201201466","volume":"2013","author":"P Dabrowski-Tumanski","year":"2013","unstructured":"Dabrowski-Tumanski, P., Kowalska, J. & Jemielity, J. Efficient and rapid synthesis of nucleoside diphosphate sugars from nucleoside phosphorimidazolides. Eur. J. Org. Chem. 2013, 2147\u20132154 (2013).","journal-title":"Eur. J. Org. Chem."},{"key":"63731_CR27","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.1021\/ol5026876","volume":"16","author":"T Li","year":"2014","unstructured":"Li, T., Tikad, A., Pan, W. & Vincent, S. P. beta-stereoselective phosphorylations applied to the synthesis of ADP- and polyprenyl-beta-mannopyranosides. Org. Lett. 16, 5628\u20135631 (2014).","journal-title":"Org. Lett."},{"key":"63731_CR28","unstructured":"Nagata, H. et al. Toll-like receptor 9 agonists. US20100016250 (2010)."},{"key":"63731_CR29","unstructured":"Xu, T. et al. Compositions And Methods of Modulating The Immune Response By Activating Alpha Protein Kinase 1. https:\/\/www.patents.google.com\/patent\/US11149051B2\/en (2023)."},{"key":"63731_CR30","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1002\/hep.32614","volume":"77","author":"C Xu","year":"2023","unstructured":"Xu, C. et al. Alpha-kinase 1 (ALPK1) agonist DF-006 demonstrates potent efficacy in mouse and primary human hepatocyte (PHH) models of hepatitis B. Hepatology 77, 275\u2013289 (2023).","journal-title":"Hepatology"},{"key":"63731_CR31","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1126\/science.aaa4921","volume":"348","author":"RG Gaudet","year":"2015","unstructured":"Gaudet, R. G. et al. Cytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity. Science 348, 1251\u20131255 (2015).","journal-title":"Science"},{"key":"63731_CR32","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/nbt.2017","volume":"29","author":"T Anastassiadis","year":"2011","unstructured":"Anastassiadis, T., Deacon, S. W., Devarajan, K., Ma, H. & Peterson, J. R. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat. Biotechnol. 29, 1039\u20131045 (2011).","journal-title":"Nat. Biotechnol."},{"key":"63731_CR33","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1167\/iovs.12-9662","volume":"53","author":"MJ Mattapallil","year":"2012","unstructured":"Mattapallil, M. J. et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL\/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest. Ophthalmol. Vis. Sci. 53, 2921\u20132927 (2012).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"63731_CR34","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1152\/jn.00055.2017","volume":"118","author":"F Kretschmer","year":"2017","unstructured":"Kretschmer, F., Tariq, M., Chatila, W., Wu, B. & Badea, T. C. Comparison of optomotor and optokinetic reflexes in mice. J. Neurophysiol. 118, 300\u2013316 (2017).","journal-title":"J. Neurophysiol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63731-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63731-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63731-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T07:00:07Z","timestamp":1757487607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63731-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,9]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63731"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63731-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,9]]},"assertion":[{"value":"30 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jieqing Fan, Danyang Liu, Zhu Ming, Chunyu Yan, Yanfang Pan, Huaixin Dang, Xiong Wei, Zhengle Zhao, Wenzhi Wang, Zhenjie Chen, Junlin Zhou, Shuai Zhang, Tong-Ruei R Li, Lawrence Melvin, Jeysen Yogaratnam, Henri Lichenstein, Tian Xu, and Cong Xu own stock in Drug Farm Inc., which funded this work and is the parent company of Shanghai Yao Yuan Biotechnology Ltd, Zhejiang Yao Yuan Biotechnology Ltd, and Drug Farm USA LLC. Vinit Mahajan is a consultant for Drug Farm. Danyang Liu, Cong Xu, Lawrence Melvin, Wei Xiong, Tongruei Raymond Li, Jieqing Fan, Yanfang Pan, Huaixin Dang, Henri Lichenstein and Tian Xu are inventors on two international patent applications filed by Shanghai Yao Yuan Biotechnology Ltd. (PCT\/CN2021\/119801, filed on September 23 2021, and #19\/036,564, filed on January 24, 2025), which are based on the work described in the article. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8251"}}